119 related articles for article (PubMed ID: 30683841)
1. KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis.
Wu MC; Cheng HH; Yeh TS; Li YC; Chen TJ; Sit WY; Chuu CP; Kung HJ; Chien S; Wang WC
Cell Death Dis; 2019 Jan; 10(2):68. PubMed ID: 30683841
[TBL] [Abstract][Full Text] [Related]
2. KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner.
Wang XY; Li HM; Xia R; Li X; Zhang X; Jin TZ; Zhang HS
Mol Cell Biochem; 2024 Apr; 479(4):915-928. PubMed ID: 37249813
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis.
Pichavaram P; Jablonowski CM; Fang J; Fleming AM; Gil HJ; Boghossian AS; Rees MG; Ronan MM; Roth JA; Morton CL; Zambetti GP; Davidoff AM; Yang J; Murphy AJ
Mol Cancer Ther; 2024 Apr; 23(4):478-491. PubMed ID: 37988559
[TBL] [Abstract][Full Text] [Related]
4. The histone demethylase JMJD2B regulates endothelial-to-mesenchymal transition.
Glaser SF; Heumüller AW; Tombor L; Hofmann P; Muhly-Reinholz M; Fischer A; Günther S; Kokot KE; Hassel D; Kumar S; Jo H; Boon RA; Abplanalp W; John D; Boeckel JN; Dimmeler S
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4180-4187. PubMed ID: 32034099
[TBL] [Abstract][Full Text] [Related]
5. Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation.
Duan L; Chen Z; Lu J; Liang Y; Wang M; Roggero CM; Zhang QJ; Gao J; Fang Y; Cao J; Lu J; Zhao H; Dang A; Pong RC; Hernandez E; Chang CM; Hoang DT; Ahn JM; Xiao G; Wang RT; Yu KJ; Kapur P; Rizo J; Hsieh JT; Luo J; Liu ZP
Nucleic Acids Res; 2019 Dec; 47(22):11623-11636. PubMed ID: 31647098
[TBL] [Abstract][Full Text] [Related]
6. KDM4A regulates the maternal-to-zygotic transition by protecting broad H3K4me3 domains from H3K9me3 invasion in oocytes.
Sankar A; Lerdrup M; Manaf A; Johansen JV; Gonzalez JM; Borup R; Blanshard R; Klungland A; Hansen K; Andersen CY; Dahl JA; Helin K; Hoffmann ER
Nat Cell Biol; 2020 Apr; 22(4):380-388. PubMed ID: 32231309
[TBL] [Abstract][Full Text] [Related]
7. Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.
Sha J; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W
J Cell Physiol; 2020 Mar; 235(3):2129-2138. PubMed ID: 31468537
[TBL] [Abstract][Full Text] [Related]
8. Targeted Downregulation of
Park SY; Seo J; Chun YS
J Korean Med Sci; 2019 Aug; 34(33):e225. PubMed ID: 31436053
[TBL] [Abstract][Full Text] [Related]
9. Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells.
Wang H; Chen H; Jiang Z; Lin Y; Wang X; Xiang J; Peng J
Pathol Res Pract; 2019 Sep; 215(9):152531. PubMed ID: 31320250
[TBL] [Abstract][Full Text] [Related]
10.
Ford AC; Yuan Y; Moayyedi P
Gut; 2020 Dec; 69(12):2113-2121. PubMed ID: 32205420
[TBL] [Abstract][Full Text] [Related]
11. KDM4B: A Nail for Every Hammer?
Wilson C; Krieg AJ
Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30759871
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation of cytokine expression in gastric cancer: influence on angiogenesis, metastasis and chemoresistance.
Reyes ME; Pulgar V; Vivallo C; Ili CG; Mora-Lagos B; Brebi P
Front Immunol; 2024; 15():1347530. PubMed ID: 38455038
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.
Kim TD; Gu R; Janknecht R
Int J Biochem Mol Biol; 2023; 14(6):101-115. PubMed ID: 38213775
[TBL] [Abstract][Full Text] [Related]
14. KDM4B: A promising oncology therapeutic target.
Ni F; Tang H; Cheng S; Yu Y; Yuan Z; Chen Y; Zhang E; Wang X
Cancer Sci; 2024 Jan; 115(1):8-16. PubMed ID: 37923555
[TBL] [Abstract][Full Text] [Related]
15. Tumor hypoxia: From basic knowledge to therapeutic implications.
Liao C; Liu X; Zhang C; Zhang Q
Semin Cancer Biol; 2023 Jan; 88():172-186. PubMed ID: 36603793
[TBL] [Abstract][Full Text] [Related]
16. CAMSAP2 promotes colorectal cancer cell migration and invasion through activation of JNK/c-Jun/MMP-1 signaling pathway.
Wang X; Liu Y; Ding Y; Feng G
Sci Rep; 2022 Oct; 12(1):16899. PubMed ID: 36207462
[TBL] [Abstract][Full Text] [Related]
17. JMJD family proteins in cancer and inflammation.
Manni W; Jianxin X; Weiqi H; Siyuan C; Huashan S
Signal Transduct Target Ther; 2022 Sep; 7(1):304. PubMed ID: 36050314
[TBL] [Abstract][Full Text] [Related]
18. Chromatin Dynamics in Digestive System Cancer: Commander and Regulator.
Li Z; Zhao B; Qin C; Wang Y; Li T; Wang W
Front Oncol; 2022; 12():935877. PubMed ID: 35965507
[TBL] [Abstract][Full Text] [Related]
19. Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.
Liu JS; Fang WK; Yang SM; Wu MC; Chen TJ; Chen CM; Lin TY; Liu KL; Wu CM; Chen YC; Chuu CP; Wang LY; Hsieh HP; Kung HJ; Wang WC
J Biomed Sci; 2022 May; 29(1):29. PubMed ID: 35534851
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic and Drug Discovery Analyses Reveal Natural Compounds Targeting the KDM4 Subfamily as Promising Adjuvant Treatments in Cancer.
Del Moral-Morales A; Salgado-Albarrán M; Ortiz-Gutiérrez E; Pérez-Hernández G; Soto-Reyes E
Front Genet; 2022; 13():860924. PubMed ID: 35480330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
